Top Qs
Timeline
Chat
Perspective

Dopamine receptor D3

Subtype of Dopamine Receptor From Wikipedia, the free encyclopedia

Dopamine receptor D3
Remove ads

Dopamine receptor D3 is a protein that in humans is encoded by the DRD3 gene.[5][6]

Quick Facts DRD3, Available structures ...
Remove ads

This gene encodes the D3 subtype of the dopamine receptor. The D3 subtype inhibits adenylyl cyclase through inhibitory G-proteins. This receptor is expressed in phylogenetically older regions of the brain, suggesting that this receptor plays a role in cognitive and emotional functions.[citation needed] It is a target for drugs which treat schizophrenia, drug addiction, and Parkinson's disease.[7] Alternative splicing of this gene results in multiple transcript variants that would encode different isoforms, although some variants may be subject to nonsense-mediated decay (NMD).[6] On a side note, it is also the Dopamine Receptor sub-type possessing the highest binding affinity for Dopamine itself and may explain why non-ergoline Dopamine Agonists are D3-preffering[8]


Remove ads

Function

Alpha-synuclein (α-Syn) aggregation via Lewy bodies inclusion, a pathogenic signature exclusively present in PD patients, is decreased by D3 agonists while DA content is elevated by inhibiting DA reuptake and breakdown. The regulation of α-Syn aggregation and clearance enhances brain-derived neurotrophic factor (BDNF) secretion, which ultimately ameliorates neuroinflammation and oxidative stress while promoting neurogenesis and interacting with other DA receptors.[9][10]

D3 agonists like 7-OH-DPAT, pramipexole, and rotigotine, among others, display antidepressant effects in rodent models of depression.[11][12] Apomorphine has the ability to help PD patients with their cognition awareness.[13] In addition to having antidepressant properties such as regulating the depression-like behaviors and depression development, pramipexole has the capability to prevent and slow down cell apoptosis as well as to restore damaged neural networks and connections while rotigotine help PD patients to attenuates hyperpyrexia syndrome and schizophrenia.[14][15]

Remove ads

Animal studies

D3 agonists have been shown to disrupt prepulse inhibition of startle (PPI), a cross-species measure that recapitulates deficits in sensorimotor gating in neuropsychiatric disorders such as schizophrenia.[16][17][18] In contrast, D3-preferring antagonists have antipsychotic-like profiles in measures of PPI in rats.[19]

Ligands

Thumb
2D-Skeletal Formula of 3 common non-ergoline DA agonists and Dopamine

Agonists

Partial agonists

Antagonists

Allosteric modulators

Remove ads

Interactions

Dopamine receptor D3 has been shown to interact with CLIC6[36] and EPB41L1.[37]

DRD3 Ser9Gly polymorphism(rs6280), which is a single nucleotide polymorphism (SNP) with variant base C/T is linked to variation in PD such as depression severity, impulse control disorders, behavioral addiction and aberrant decision-making.[38][39][40][41]

References

Loading content...

Further reading

Loading content...
Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.

Remove ads